Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128439 · ClinicalTrials.gov registry record
Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1
- Enrollment target
NCT01128439 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1 participants.
The verdict
NCT01128439 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01128439
The ClinicalTrials.gov registry entry for NCT01128439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT01128439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01128439 about?
NCT01128439 is a clinical study titled "Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease". This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
What is the current status of trial NCT01128439?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2010-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01128439?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01128439?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.